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Abstract Total protein kinase C (PKC) activity and protein 
expression of the c~ and 6 subspecies of PKC increases markedly 
as C6 glioma cells grow from low cell density to the contact- 
inhibited quiescent state (also known as Go) in the presence of 
serum. At the same time protein expression of PKC subspecies 
y and e decreases while the iBl, ~ID t and ~ subspecies did not 
change. Serum deprivation of growing C6 glioma cells does not 
induce the same changes in PKC subspecies protein expression. 
The findings support the growing view that there are significant 
differences between the Go states brought about by contact inhi- 
bition or serum deprivation. 
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1. Introduction 
The mitogenic effect of growth factors and phorbol esters is 
mediated through the protein kinase C (PKC) family of phos- 
pholipid-dependent serine/threonine kinases [1,2] which can ac- 
tivate proliferation-associated g nes via Raf and the MAP ki- 
nase pathway [3,4]. The twelve subspecies of PKC identified to 
date fit into three main groups, the conventional (c) PKC sub- 
species c~, fl~,/3, and ~" requiring calcium and diacylglycerol 
(DAG), the novel (n) calcium-independent PKC subspecies ~, 
e, r/, ~t and 0 activated by DAG and the atypical (a) subspecies 
5, t and 2 being both calcium and DAG independent [5]. The 
c and n PKC subspecies are activated by phorbol esters [1,2]. 
Some PKC subspecies such as ~, 6 and ~" are widely expressed 
whereas the 7, r/and 0 subspecies have a restricted istribution 
[1,2,5]. The role of individual PKC subspecies ingrowth regula- 
tion is not well defined though PKC a activates Raf-1 by direct 
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ethylenediaminetetraacetic id; EGTA, ethylene glycol-bis(fl-amino- 
ethyl ether)-N,N, ',N'-tetraacetic acid; FBS, foetal bovine serum; HB, 
homogenisation buffer; MBP, myelin basic protein; PBS, phosphate- 
buffered saline; PKC, protein kinase C; PMSF, phenylmethyl sul- 
phonyl fluoride; SDS, sodium dodecylsulphate; TBS, Tris-buffered sa- 
line; TBST, Tris-buffered saline/0.2% Tween 20. 
phosphorylation [4]. Over-expression f c and n group PKC 
subspecies incells causes contrasting effects on growth rate and 
cell morphology (summarised in [6,7]) while the downregula- 
tion-sensitive PKC subspecies (cz,/3, 6, e) regulate cyclin-de- 
pendent kinases in endothelial cells [8]. 
Serum deprivation or contact inhibition at high cell density 
causes cells to enter the quiescent stage of the cell cycle, also 
called Go, characterised bya smaller cell size, decreased protein 
synthesis and monosomal ribosomes [9]. Quiescence due to 
contact-inhibition at high cell density has been ascribed to a 
lack of growth factors rather than to specific cell-cell interac- 
tions [10]. However, membrane tyrosine phosphatase activity 
is increased in density-dependent quiescent 3T3 cells but not in 
serum-deprived cells [11] while the serum deprivation response 
(sdr) gene is induced in serum starved but not contact-inhibited 
cells [10]. Go induced by high cell density may thus be different 
from the serum starvation condition. Here we show that PKC 
activity and PKC subspecies protein expression changes as C6 
glioma cells become contact inhibited at high cell density. Such 
changes do not occur on serum starvation. 
2. Materials and methods 
2. I. Materials 
C6 glioma cells were from the European Collection of Animal Cell 
Cultures (Porton Down, England, UK). Cell culture plastic was from 
Nunc (Life Technologies, Paisley, Scotland, UK) or Coming (Bibby- 
Sterilin, Stone, Staffs, UK). DMEM was from Flow Laboratories 
(Thame, Oxon, UK) and foetal bovine serum was from Advanced 
Protein Products. [3H]Thymidine and the ECL detection system were 
from Amersham Int. (Little Chalfont, Bucks, UK). [33p]ATP (1000- 
3000 Ci/mmol, NEG-302H) was from NEN/DuPont (UK) Ltd. (Ste- 
venage, Herts, UK). Cellulose nitrate blotting membrane (0.2/.tin) was 
from Schleicher and Schuell (Anderrnan, London, UK). BCA and 
Coomassie protein detection systems were from Pierce (Life Science 
Labs., Luton, England, UK). P-81 paper was from Whatman Int. Ltd. 
(Maidstone, England, UK). Leupeptin, aprotinin, PMSF, bovine serum 
albumin and peroxidase-conjugated second antibodies were from 
Sigma. Dried milk powder, Marvel, was from KwikSave (Hull Road, 
York, UK) 
2.2. Cell culture and FH]thymidine incorporation 
C6 cells were grown in DMEM/10% FBS in 25 or 75 cm 2 cell culture 
flasks. Medium was changed every two days. At confluency ells were 
split 1:4 and passaged into similar flasks or into six-well plates for 
thymidine incorporation and cell number assays. Cells were harvested 
at different stages of growth. 100% confluent cells were allowed to grow 
on further, with or without changes of medium, before being harvested. 
Cells were photographed under phase contrast optics onto T-max film. 
C6 cells at different stages of growth in six-well plates were incubated 
at 37°C for 60 rain with 1 ml DMEM containing 1 ,uCi [3H]thyrnidine. 
Cells were then rinsed with cold Tris-saline, trypsinised from wells, 
counted using a haemocytometer and then recovered by low speed 
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centrifugation. The cell pellet was rinsed with Tris-saline and homogen- 
ised in 1 ml water. Aliquots were taken for TCA precipitation. TCA- 
precipitated material was collected on GF/A filters which were rinsed 
and dried, prior to scintillation counting. Corresponding wells of C6 
cells were scrapped into 1 ml distilled water and homogenised for 
protein estimation by the BCA method. 
2.3. Protein kinase C assay 
PKC activity was assayed by measuring the transfer of ),-phosphate 
from [33P]ATP to a synthetic peptide substrate (MBP4_~4). It is known 
that PKC subspecies 0~, fl, 7/, ~ and e phosphorylate his substrate [12] 
although it is reported to be a poor substrate for PKC ( [13]. Our 
procedure has been described in full previously [14] and is based on the 
previous method of Kikkawa et al [15]. C6 cells were rinsed twice with 
cold Tris-saline and scraped into homogenisation buffer (20 mM Tris- 
HC1, pH 7.5, 0.5 mM EDTA, 2 mM EGTA, 10/.tg/ml aprotinin, 10 
/ag/ml eupeptin and 5 mM PMSF) containing 1% Triton X-100. Ex- 
tracts were homogenised, mixed on ice for 30 min and centrifuged at 
100,000 × g for 15 min. The supernatants were fractionated on DE-52 
columns and total PKC activity eluted with column buffer (20 mM 
Tris-HC1, pH 7.5, 2 mM EDTA, 0.5 mM EGTA, 0.1%fl-mercaptoetha- 
nol) containing 200 mM NaCI. PKC activity was assayed using MBP,~j4 
peptide (50/Lmol) in the presence or absence of an inhibitor peptide (50 
,umol) based on the pseudosubstrate site of PKC a, Additionally assays 
contained buffer (20 mM Tris-HC1, pH 7.5), Mg 2÷ (1.25/tmol), diolein 
(0.2/~g) and phosphatidylserine (10/lg). Assays (250/zl total volume) 
of calcium independent activity were performed in the presence of 
EGTA (125 nmol) and no calcium whereas total PKC was performed 
with calcium (125 nmol). Reactions were initiated by the addition of 2.5 
nmol ATP containing 0.05/iCi [33P]ATP (NEN) and were incubated for 
15 min at 30°C. Reactions were terminated by spotting aliquots of 
reaction incubations onto P-81 phosphocellulose paper (in quadrupli- 
cate) which was then washed 4 times in phosphoric acid (80 raM). The 
P-81 paper strips were rinsed in distilled water, finally in acetone and 
then air-dried for scintillation counting. All results are expressed as 
specific activity (pmol 33p-transferred/15 min//~g protein or as dpm//tg 
protein and are + the standard eviation or are typical results from at 
least three repeats. 
2.4. Immunodetection f PKC subspecies 
Polyclonal antisera to the C-terminal sequences of rat PKC subspe- 
cies ct, ill, fllI, y, 6, e, ( and r/were raised and characterised asdescribed 
[14,16]. C6 cells were rinsed twice in flasks with cold Tris-saline and 
were then scraped into homogenisation buffer (HB) without Triton 
X-100. Cells were homogenised, protein assayed using the Pierce BCA 
method and aliquots olubilised at a ratio of2:1 : 1 (v/v) with 10% SDS 
and sample buffer followed by boiling for 5 min. Samples equivalent 
to 25/.tg protein plus rat brain controls and suitable markers were 
resolved on 10% SDS-polyacrylamide gels at a constant 120 V and were 
then transferred to nitrocellulose membrane in 25 mM Tris base, 180 
mM glycine containing 10% methanol (v/v) for 75 min with a constant 
current of 250 mA. Subsequent Western blotting with ECL detection 
was under standard conditions as we have described [14]. Primary 
antibodies were used at 1:2000. Detection of second antibody was by 
the ECL technique with X-O-graph blue film (X-O-graph, Malmsbury, 
Wilts., UK). Developed films were analysed using an enhanced laser 
densitometer (LKB). 
3. Results 
3.1. Cells growth 
Phase contrast micrographs of C6 glioma cells at approxi- 
mately 50%, 75% and 100% confluency, and quiescence, are 
shown in Fig. 1. Percent confluency was judged by the area of 
substratum in a field of view covered by growing cells. At 100% 
confluency no substratum was visible. Cells were cultured for 
up to seven more days (100/2, 4, etc.) with or without medium 
change depending on the experiment. At low confluency C6 
cells were elongated in shape, about 15/lm in length. At 100% 
confluency the cells still retained this elongated shape but at 
quiescence they had rounded up and had a diameter of about 
10/.tin. Cell number per well increased steadily after the point 
where cells first completely covered the substratum (Fig. 2A). 
and doubled in the two days after cells first reached 100% 
confluency. After this point there was no further increase in cell 
numbers and incorporation of [3H]thymidine decreased ra- 
matically (Fig. 2B). After 4-7 days at full confluency, with or 
without changes of medium, C6 cells show little [3H]thymidine 
incorporation indicative of the quiescent Go state. 
Fig. 1. Phase contrast micrographs of C6 glioma cells at different states of confluency in DMEM/10% FBS medium. (A) 50%; (B) 7~80%; (C) 100%; 
(D) quiescent. Magnification: ×330. 
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Fig. 2. Changes in (A) C6 cell number and (B) incorporation of[3H]thymidine into C6 glioma cells growing in DMEM/10% FBS at different states 
of confluency. 100/2, 100/4 and 100/7 are 2, 4 and 7 days after cells become 100% confluent. Cell numbers were obtained by trypsinising cells from 
wells and counting with a haemocytometer, [3H]Thymidine incorporation was as described in section 2. 
3.2. Protein kinase C activity changes during C6 cell growth 
As C6 cells grow to confluency the specific activity of both 
calcium-independent PKC subspecies and total PKC activity 
increases (Fig. 3), specific activity being highest in cells just 
reaching full confluency. PKC specific activity in quiescent C6 
cells was decreased compared with the 100% confluency figure 
but values were still approximately double the levels in cells 
growing at 50% confluency with few cell--cell contacts. Serum 
deprivation for 24 h did not increase PKC specific activity 
compared with cells growing in the presence of serum (data not 
shown). 
3.3. Protein kinase C subspecies protein expression during C6 
cell growth 
PKC subspecies protein expression was compared by loading 
equal amounts of C6 cell protein (25/.tg) from cells at different 
growth stages onto gels which were then run, blotted and devel- 
oped under standard conditions [14]. Samples of rat brain were 
always included as positive controls and peptide controls were 
also included for band identification. Blots were repeated at 
least twice with fresh samples of C6 cells at approximately 
similar stages of growth. The experiments confirmed [16] that 
C6 cells express PKC subspecies ~, fl~, fin, Y, 6, ~ and ~" at the 
expected molecular weights with the exception of the fl~ and flH 
PKC subspecies which were always detected as bands of 40 
kDa. We assume that these are proteolytic breakdown products 
since these were competed out with the appropriate peptide and 
appear in 6-week-old rat brain samples together with bands at 
the correct 80 kDa position. PKC subspecies q,y amd 0 were 
not detected in C6 cells but were detected in 6-week-old rat 
brain (r/and ~t) and rat muscle (0) controls. PKC t is expressed 
in C6 cells as a band at 90 kDa. 
Protein expression of PKC subspecies e and ~ increases 
markedly as cells grow to confluency and become quiescent by 
contact inhibition in the presence of serum (Fig. 4A,C). Laser 
scanning of ECL bands showed that in quiescent C6 ceils PKC 
subspecies expression increased by 2-3-fold and PKC g by 
over 4-fold compared with cells at 50% confluency. For the 2/ 
and e subspecies of PKC the opposite trend was detected: 
protein expression decreased as cells became confluent and 
these subspecies were barely detected in quiescent C6 ceils (Fig. 
4B,D). Protein expression of the e subspecies decreased by as 
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Fig. 3. Protein kinase C activity associated with C6 glioma cells at 
different stages of density-dependent growth arrest. Calcium-independ- 
ent (nPKC) and total PKC activity were assayed as described in section 
2. Results are means of specific activity from six replicates and are 
+S.D. Quiescent cells (Q) were 100% confluent cells grown for a 
further four days in the presence of serum. 
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Fig. 4. Western blot analyses of PKC ~ (A), PKC y (B), PKC 6 (C), PKC e (D), PKC ~" (E) and MARCKS (F) protein expression (arrows) in C6 
glioma cells growing in DMEM/10% FBS at 50% (lane 3), 75% (lane 4), 100% confluency (lane 5) and quiescence - 100% + 4 days (lane 6). For all 
blots lane 1 is 6 week rat brain control + specific C-terminal peptide to block antibody, lane 2 is 6-week rat brain control, lanes 7 and 8 are 50% 
and quiescent C6 cells respectively +C-terminal peptide to block antibody. Bars indicate marker positions, from top 123, 89, 67, 50, 37.5 and 34 
kDa. 
much as 90% as cells became confluent and quiescent. Our 
anti-PKC e antibody always detected two bands for the ~ sub- 
species in C6 cells with molecular sizes of 95 kDa and 87 kDa 
(Fig. 4D). These both were competed out by the specific pep- 
tide. The 87 kDa molecular weight form was expressed strongly 
in rapidly growing C6 cells, expression decreasing as cells be- 
came contact inhibited at confluency and quiescence when the 
higher molecular weight form became more apparent. Protein 
expression of ill, • l l ,  t and ( PKC subspecies did not change as 
C6 cells grew to confluency and quiescence. For these subspe- 
cies the blot for PKC ( is shown as an example (Fig. 4E). The 
protein expression changes in PKC subspecies are summarised fl, 
in Table 1. MARCKS protein expression increased as cells /~" 
Y 
grew to confluency (Fig. 4F) but was decreased in contact 
inhibited quiescent C6 cells. 
Removal of serum from growing C6 cells for 48 h did not 695 
~87 
result in the same changes in PKC subspecies protein expres- 
/7 
sion as contact inhibition after 100% confluency (Fig. 5). There /~ 
was no increase in the 0~ and 6 subspecies as found for cells 0 
becoming quiescent by contact inhibition (Fig. 5A,C), and there 
was no decrease in the y and e subspecies (Fig. 5B,D). ( 
l 
4. Discussion 
Quiescent cells in an 'out of cycle' G o state have a decreased 
size and generally lowered rates of macromolecule synthesis 
and of enzymatic and membrane transport processes [9]. Such 
quiescent growth-arrested cells are still active, however, since 
synthesis of some specific RNA and proteins characteristic of 
Table 1 
Relative PKC subspecies protein expression as C6 cells reach quies- 
cence 
PKC isoform Relative PKC expression 
50% C6 100% C6 Quiescent C6 
+ ++ +++ 
+ + + 
+ + + 
+ +/ - -  +/___ 
+ +++ ++++ 
+ >+ ++ 
+ +/ - -  +/ - - -  
+ + + 
+ + + 
'+' signifies 'normal' expression i  rapidly dividing cells (50% confluent 
C6); and ' - '  signifies no protein expression of a PKC isoform. The 
increases and decreases are arbitary units derived from laser densito- 
metric scanning of ECLs. 695 is PKC e of 95 kDa and e87 is PKC e of 
87 kDa. 
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Fig. 5. Western blot analysis of protein expression changes in PKC 
(A), PKC y (B), PKC ~ (C) and PKC e (D) as C6 glioma cells reach 
50% confluency (lane 1) or quiescence (lane 3) in DMEM/10% FBS 
compared with 50% confluent cells in DMEM/0.1% FBS for 48 h (lane 
2). Lane 4 is as lane 2 but blots were incubated with the appropriate 
C-terminal peptide to block antibody. Bars indicate marker positions, 
from top 123, 89, 67, 50, 37.5 and 34 kDa. 
the Go state occurs [10,17] and several gas (growth arrest- 
specific) genes, induced by both serum starvation or contact 
inhibition, have been defined (summarised in [10]). Differences 
in the Go state induced by serum starvation or density-depend- 
ent contact inhibition have been identified. For example, a 
serum deprivation response (sdr) gene is activated when 
NIH3T3 cells are made quiescent by serum removal but not by 
contact inhibition [10] while contact inhibited, but not serum- 
deprived, Swiss 3T3 cells in Go show elevated membrane tyro- 
sine phosphatase activity [11]. MARCKS protein expression is
increased in serum-starved cells in Go [18] but we find here that, 
though contact inhibition also increases protein expression of 
MARCKS protein as cells grow to confluency, in quiescence 
expression is subsequently decreased. 
Involvement of PKC in the regulation of cell growth is well 
established [19,20] and in C6 cells PKC activity changes with 
different stages of the cell cycle being highest in Go [21]. How- 
ever, the role of individual PKC subspecies in the regulation of 
cell growth is poorly understood [6-8] though PKC ~ is a 
RAF-1 kinase [4] which provides one route to activation of 
certain early response genes. Here we show that PKC activity 
and protein expression of the ~ and ~ subspecies of PKC in- 
creases as C6 cells become growth-arrested by contact inhibi- 
tion in the presence of serum while protein expression of the 
y and e subspecies decreases, these subspecies being barely 
detected in contact-inhibited quiescent C6 cells. The rise in 
PKC specific activity as C6 cells grow to 100% confluency can 
be ascribed to the increased protein expression of the ~ and 6 
subspecies since we have studied all PKC subspecies available 
and only the ~ and d subspecies show an increase in protein 
expression. These changes in PKC subspecies expression do not 
occur when growing C6 cells are deprived of serum for 24-48 
h (Fig. 5A,C). Thus we have found another difference between 
density-dependent contact inhibition entry into Go and the 
serum-deprivation mechanism. 
The detection of two forms of PKC e is particularly interest- 
ing and preliminary studies how that the low molecular weight 
form is exclusively associated with the cytosol while the high 
form, which is expressed as cells become quiescent, is princi- 
pally membrane associated. Similarly, immunocytochemical 
staining shows that in growing C6 cells PKC e is diffusely 
distributed throughout the cell but at quiescence it is largely 
plasma membrane associated and is detected as a rim of fluores- 
cence at the cell periphery. Our current hypothesis i that the 
95 kDa band is a more phosphorylated form. 
The PKC subspecies changes we have observed occur in 
addition to any role for PKC subspecies in normal cell cycle 
control [8,21] since the cells go through several complete cell 
cycles of division before reaching quiescence. How the changes 
in PKC subspecies protein expression are triggered is not yet 
clear. Increasing surface contacts between cells can influence 
expression since addition of plasma membrane or surface mem- 
brane protein preparations to growing cells reduces cell growth 
rate (summarised in [22]). A purified plasma membrane 
glycoprotein, contactinhibin, inhibits growth of sparsely- 
seeded fibroblasts [22]. Further, growth of proliferating fibro- 
blasts is inhibited by an antibody to N-CAM at the cell surface 
[23]. Integrin binding to the extracellular cell matrix causes 
changes in gene expression through the focal adhesion kinase 
pp125 yAK [24]. Thus pathways to the nucleus from integrin, cell 
adhesion and other molecules involved in cell-cell contacts 
exist. The increased PKC subspecies expression may also be 
due to a reduction in signals from growth factors in the medium 
as cells are of much reduced size at quiescence [10]. This is less 
likely in our view since the major changes in PKC activity and 
subspecies expression are triggered while cells are growing to 
100% confluency and are of approximately similar size. Why 
do C6 cells growing to quiescence increase xpression of PKC 
and ~ and decrease xpression of PKC 7 and e? Such changes 
may be regulating entry to Go, slowing down the cell cycle. The 
negative cell cycle regulator protein p53 is a substrate for PKC 
[25]. It is also perhaps relevant hat overexpression f PKC 
in 3T3 cells decreases the cell surface density of epidermal 
growth factor receptors [26]. Thus the increase in PKC ~ ex- 
pression we detect as C6 cells grow to quiescence may decrease 
cell growth by causing a reduction in positive signals from 
growth factors in the medium. Additionally, or alternatively, 
the change in PKC subspecies may be a preparation for subse- 
quent re-entry to G1. Activity of a membrane tyrosine kinase 
is also increased in contact-inhibited tibroblasts [8]. We find 
that similar PKC changes occur when L929 fibroblasts and 
astrocytes in primary culture grow to confluency (Williams, 
Moreton and Rumsby, in preparation). The results indicate 
that in studies on PKC the degree of cell confluency is clearly 
of importance when making activity or expression measure- 
ments. 
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